FLGTFulgent Genetics, Inc.
$20.11-14% 1Y
$20.11
$13.7952 weeks$30.85
Is the price fair?
What FLGT's price assumes
Fulgent Genetics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1.77× revenue.
1.77
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.57
Price / book · as of 2026-Q2
- EV / sales
- 0.98
EV / sales
Details›
- Price / bookas of 2026-Q2
- 0.57
- EV / EBIToperating margin −38%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 0.98
- Market capitalisation27.5 million shares, counted Jul 27, 2026
- $553M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Diagnostics & Research
Ranks #13 of 21 by RyuScore